Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and synechiae formation. However, there is a paucity of...

Full description

Bibliographic Details
Main Authors:	Phayvanh P. Sjogren Ph.D., Noah P. Parker M.D., Holly C. Boyer M.D.
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-03-01
Series:	Allergy & Rhinology
Online Access:	https://doi.org/10.2500/ar.2013.4.0042

Similar Items

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

Mechanism of Drug-Eluting Stent Thrombosis Diagnosed by Histopathological Evaluation of Directional Coronary Atherectomy Specimen
by: Kazuki Ito, MD, et al.
Published: (2023-12-01)

Pathological evaluation of a fluoropolymer-based drug-eluting stent in an arteriovenous graft outflow venous stenosis
by: Kotaro Suemitsu, MD, PhD, et al.
Published: (2024-06-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
by: Yujin Yang, MD, et al.
Published: (2021-09-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
by: Hanbit Park, MD, et al.
Published: (2021-10-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Different patterns of in-stent coverage in drug-eluting stents
by: Daniele Gemma, et al.
Published: (2017-11-01)

Optimization of Drug Delivery by Drug-Eluting Stents.
by: Franz Bozsak, et al.
Published: (2015-01-01)

Very Early Progression of an In-Stent Calcified Nodule 2 Weeks After Drug-Eluting Stent Implantation in the Calcified LesionNovel Teaching Points
by: Naoko Higashino, MD, et al.
Published: (2022-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
by: А. Н. Кудряшов, et al.
Published: (2017-04-01)

The Potential Role of Bacteriophages in the Treatment of Recalcitrant Chronic Rhinosinusitis
by: Saartje Uyttebroek, et al.
Published: (2021-06-01)

Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis
by: Mian L. Ooi, et al.
Published: (2018-04-01)

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus
by: Alexander Thomas, MD, et al.
Published: (2022-03-01)

Drug-Eluting Stents: Technical and Clinical Progress
by: Maciej Koźlik, et al.
Published: (2023-02-01)

Studies of biodegradable drug-eluting tracheal stents
by: Ng, Anthony Herr Cheun
Published: (2012)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Drug-eluting stents : Insights into safety and indications
by: Hassan Walid
Published: (2008-01-01)

Contemporary Drug-Eluting Stents and Vascular Response
by: Anwer Habib, et al.
Published: (2017-03-01)

Are Drug Eluting Stents Worth Triple Therapy?
by: Paul Heidenreich
Published: (2017-08-01)

Drug-eluting stent: a review and update
by: Thein Htay, et al.
Published: (2005-12-01)

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma
by: Yusuke Imai, MD, et al.
Published: (2017-03-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-07-01)

Angioplasty and drug-eluting stent for vertebral artery stenosis
by: Nabil A Metwally, et al.
Published: (2018-01-01)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
by: Spadaccio Cristiano, et al.
Published: (2016-01-01)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.
by: Taggart, D
Published: (2008)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
by: Tatsuya Nakama, MD, et al.
Published: (2021-09-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Use of a fluoropolymer-based paclitaxel-eluting stent for arteriovenous graft outflow vein stenosis in hemodialysis patients
by: Yuki Matsuoka, MD, MBA, et al.
Published: (2021-06-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
by: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Published: (2015)

An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents
by: Navideh Abbasnezhad, et al.
Published: (2022-07-01)

Drug deposition in coronary arteries with overlapping drug-eluting stents
by: Olgac, Ufuk, et al.
Published: (2017)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
by: Imad Sheiban, et al.
Published: (2008-02-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)